Table 3.

Treatment rates by drug and across community medicine distributors

Variable	Obs.	Mean (%)	Std. Dev. (%)	Min (%)	Max (%)
% eligible individuals treated with at least one of PZQ, ALB, or IVM	59	26.08	21.79	0	84.25%
% eligible individuals treated with PZQ	59	23.88	20.24	0	72.24
% eligible individuals treated with ALB	59	20.44	19.89	0	82.78
% eligible individuals treated with IVM	59	16.95	18.49	0	82.45

PZQ praziquantel, ALB albendazole, IVM ivermectin